This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday – Amentum Holdings (NYSE:AMTM), ArriVent BioPharma (NASDAQ:AVBP)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• B. Riley Securities analyst Kalpit Patel initiated coverage on ArriVent BioPharma, Inc. AVBP with a Buy rating and announced a price target of $37. ArriVent BioPharma shares closed at $19.60 on Wednesday. See how other analysts view this stock.
• Goldman Sachs analyst Noah Poponak initiated coverage on Amentum Holdings, Inc. AMTM with a Neutral rating and announced a price target of $21. Amentum Holdings shares closed at $19.03 on Wednesday. See how other analysts view this stock.
• Morgan Stanley analyst Judah Frommer initiated coverage on Celldex Therapeutics, Inc. CLDX with an Overweight rating and announced a price target of $46. Celldex Therapeutics shares closed at $19.95 on Wednesday. See how other analysts view this stock.
• JP Morgan analyst Detlef Winckelmann initiated coverage on International Paper Company IP with an Overweight rating and announced a price target of $59. International Paper shares closed at $52.62 on Wednesday. See how other analysts view this stock.
• Scotiabank analyst Patrick Colville initiated coverage on Microsoft Corporation MSFT with a Sector Outperform rating and announced a price target of $470. Microsoft shares closed at $387.82 on Wednesday.  See how other analysts view this stock.

Considering buying MSFT stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Says TJX Is ‘Terrific,’ Recommends Buying These Stocks